Literature DB >> 30536375

Berberine reversed the epithelial-mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in the TGF-β pathway.

Chao Huang1, Liang Tao1, Xiu-Lian Wang2, Zuoliang Pang3.   

Abstract

Stroma-tumor interactions within microenvironment play a crucial role in tumor development and growth. Cellular transdifferentiation in the stroma is a prerequisite for tumor formation. Targeting the interactions maybe a promising anticancer strategy. Berberine (BBR) has been confirmed to have anticancer and anti-inflammatory effects. We found for the first time that colon cancer cells SW480 induced spindle-like morphological changes and downregulation of E-cadherin and upregulation of vimentin and alpha-smooth muscle actin in colon epithelial cells HCoEpiCs by using transwell coculture system and conditioned medium from SW480. The conditioned medium also promoted the migration of HCoEpiCs. This transition was inhibited by a transforming growth factor-β receptor inhibitor LY364947. BBR (50 and 100 µg/ml) reversed the EMT-like transition and repressed the migration in HCoEpiCs. Further results demonstrated that downregulation of TβRII, Smad2, p-Smad3, and overexpression of Smad3 participated in the SW480-induced phenotypic transition of HCoEpiCs. In addition, BBR upregulated the expressions of TβRII, Smad2, and p-Smad3. In conclusion, our findings suggest that BBR exerts the anti-EMT and antimigration effect by mediating the expression of TβRII, Smad2, and p-Smad3.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  berberine (BBR); colon cancer; epithelial-mesenchymal transition (EMT); transdifferentiation; transforming growth factor-β (TGF-β)

Mesh:

Substances:

Year:  2018        PMID: 30536375     DOI: 10.1002/jcp.27835

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Coptidis Rhizoma Suppresses Metastatic Behavior by Inhibiting TGF-β-Mediated Epithelial-Mesenchymal Transition in 5-FU-Resistant HCT116 Cells.

Authors:  Yong-Hwi Kang; Jing-Hua Wang; Jin-Seok Lee; Nam-Hun Lee; Chang-Gue Son
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway.

Authors:  Yun Jin; Jiawei Zhang; Yunfeng Pan; Wangzhen Shen
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

3.  The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo.

Authors:  He-Qi Bu; Feng Shen; Junhui Cui
Journal:  Onco Targets Ther       Date:  2019-09-11       Impact factor: 4.147

4.  Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF-β/Smad Pathway.

Authors:  Haiyan Du; Jiangyong Gu; Qin Peng; Xiaolan Wang; Lei Liu; Xuanyu Shu; Qiuying He; Yuhui Tan
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

Review 5.  Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer.

Authors:  Yi Zhu; Na Xie; Yilu Chai; Yisen Nie; Ke Liu; Yufei Liu; Yang Yang; Jinsong Su; Chuantao Zhang
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

6.  Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.

Authors:  Ge Li; Chuang Zhang; Wei Liang; Yanbing Zhang; Yunheng Shen; Xinhui Tian
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.889

7.  Quantitative Proteomics Analysis of Berberine-Treated Colon Cancer Cells Reveals Potential Therapy Targets.

Authors:  Pengfei Li; Zhifang Hao; Huanhuan Liu; Bojing Zhu; Liuyi Dang; Chen Ma; Yintai Xu; Yiyan Zhang; Daidi Fan; Shisheng Sun
Journal:  Biology (Basel)       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.